25 - 27 June 2018 | Boston, USA

Our Drug Safety and Regulatory team will be speaking alongside industry experts at DIA's 2018 Global Annual Meeting in Boston on June 26th. Mark Perrott, our Head of Development, alongside Helen Edelberg - Head of Medical Safety Assessment, Innovative Medical and Global Safety Risk Management, Bristol-Myers Squibb and Emily Freeman - Director of Patient Centered Outcomes, AbbVie, Inc. will be speaking on the topic "Risk Management: New Directions" and Richard Huckle, our expert in regulatory, will be presenting the session “Expanded Access: Where Are We Now?” with Anne Cropp - Chief Scientific Officer, Early Access Care.

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe from distinguished speakers and expert panelists to regulatory, industry, patient advocacy, and academia.

Book a meeting with our experts at DIA

Click here to view DIA's 2018 Global Annual Meeting programme